Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Active not recruiting × COVID-19 × Clear all

Phase

Phase NA 2 Phase EARLY_PHASE1 1 Phase 2 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 10 Glioma 9 Glioblastoma 8 Brain Neoplasms 7 Pancreatic Neoplasms 6 Sarcoma 5 Neoplasm Metastasis 5 Neuroendocrine Tumors 4 Neoplasms 4 Lung Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Neuroblastoma 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Smoldering Multiple Myeloma 2 Smoking Cessation 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Colorectal Neoplasms 2 Cachexia 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

NVX-CoV2373 adjuvated lipid nanoparticle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03305341 2025-06-11

COVSP-BCG

Medicine Invention Design, Inc

Phase EARLY_PHASE1 Active not recruiting

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡